ARCHIVES

ASCO: NCI Authorities Still Important

This article is from The Cancer Letter archive.

Vol. 36 No. 22 | June 11, 2010

Download PDF Visit The Full Archive

Related Articles

Phase III Xilonix Study Halted Following Unscheduled Analysis

September 26, 2014

Lawyer Says Salick didn’t Anticipate Ouster By Zeneza

May 2, 1997

Henschke: I-ELCAP Plans to Enroll 100,000 Patients In Controversial Screening Trial

June 24, 2011

Other NCI funding opportunities listed.

July 9, 2004

ACS Study Shows Reduced Mortality For Low T/N Brands

April 18, 1980

Clinton Seeks Cut In NIH Increase

May 27, 1994